P2.01-82 Neutrophil-to-Lymphocyte Ratio Complements the Prognostic Ability of PD-L1 in Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors

Journal article

Open access

Peer reviewed

D Saravia, S Agte, N Okabe, W Park, D Kwon, R Mudad, H Suzuki, Y Chae, M Oh, A Rahbari, …

Journal of thoracic oncology, Vol.13(10), pp.S696-S696

2018-10

Files and links (1)

url

https://doi.org/10.1016/j.jtho.2018.08.1136View

Published (Version of record) Open

8 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: P2.01-82 Neutrophil-to-Lymphocyte Ratio Complements the Prognostic Ability of PD-L1 in Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors
Creators: D Saravia - Hematology-Oncology, University of Miami, Miami, FL/US
S Agte - Rhlccc, Northwestern University, Chicago, IL/US
N Okabe - Fukushima Medical University, Fukushima/JP
W Park - Hematology-Oncology, University of Miami, Miami, FL/US
D Kwon - Hematology-Oncology, University of Miami, Miami, FL/US
R Mudad - Hematology-Oncology, University of Miami, Miami, FL/US
H Suzuki - Chest Surgery, Fukushima Medical University, Fukushima/JP
Y Chae - Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago,IL/US
M Oh - Northwestern University, Chicago, IL/US
A Rahbari - Northwestern University, Chicago, IL/US
G Lopes - Hematology-Oncology, University of Miami, Miami, FL/US
Publication Details: Journal of thoracic oncology, Vol.13(10), pp.S696-S696
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Department of Public Health Sciences Research; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031600723102976